California to become U.S. first state to sell cheap insulin through state-backed program
California has achieved a major healthcare milestone by launching a groundbreaking initiative to provide affordable, state-backed insulin. The pioneering CalRx program is contracting with a generic manufacturer to produce the medication, which it will sell at near-cost prices. This action is expected to drastically lower costs for the nearly $3.2 million residents living with diabetes. By intervening in the market, the state affirms that essential, life-saving medication must be affordable, setting a powerful national precedent for health equity.









